Russell Investments Group, Ltd. Merrimack Pharmaceuticals Inc Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 08, 2024	BUY	$13.06 - $15.0 $587 - $675	45 Added 4.22%	1,111 $16,000
Q4 2023 Feb 05, 2024	BUY	$12.02 - $13.41 $2,428 - $2,708	202 Added 23.38%	1,066 $14,000
Q3 2023 Nov 13, 2023	BUY	$11.6 - $12.52 $10,022 - $10,817	864 New	864 $10,000
Q1 2019 May 13, 2019	SELL	$3.19 - $5.73 $14,993 - $26,931	-4,700 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$3.91 - $4.66 $396,333 - $472,356	-101,364 Reduced 95.57%	4,700 $25,000
Q2 2018 Aug 08, 2018	SELL	$3.86 - $7.61 $1,544 - $3,044	-400 Reduced 0.38%	106,064 $521,000
Q1 2018 May 11, 2018	BUY	$6.24 - $9.15 $84,140 - $123,378	13,484 Added 14.5%	106,464 $857,000
Q4 2017 Feb 06, 2018	BUY	$7.99 - $11.87 $742,910 - $1.1 Million	92,980	92,980 $982,000

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.